GILD
NASDAQ · Biotechnology
Gilead Sciences Inc
$139.37
+3.03 (+2.22%)
EPS Surprise History
Earnings Summary
Beats (Last 4)
3/4
Avg Surprise
+3.6%
Consecutive Beats
3 quarters
Latest EPS
$1.86
History
4 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q1 FY2026 | $1.85 | — | — | — | — |
| Dec 31, 2025 | Q4 FY2025 | $1.85 | $1.86 | +$0.01 | +0.7% | Beat |
| Sep 30, 2025 | Q3 FY2025 | $2.17 | $2.47 | +$0.30 | +13.7% | Beat |
| Jun 30, 2025 | Q2 FY2025 | $2.00 | $2.01 | +$0.01 | +0.6% | Beat |
| Mar 31, 2025 | Q1 FY2025 | $1.82 | $1.81 | -$0.01 | -0.6% | Miss |
Related Earnings News
Gilead Shares Dip as Yeztugo Sales Outlook Disappoints
Eli Lilly shares retreat as $2.4B Orna acquisition and China partnership draw scrutiny
Eli Lilly Shares Dip Following $2.4 Billion Orna Therapeutics Acquisition Announcement
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus